I agree that this site is using cookies. You can find further informations here.
X
Molteni, Alfredo
87  results:
?
1

Adapting the Fitness Criteria for Non-Intensive Treatments ..:

Rossi, Giuseppe ; Borlenghi, Erika ; Zappasodi, Patrizia...
Cancers.  16 (2024)  2 - p. 386 , 2024
Link: https://doi.org/10.3390/..
 
?
2

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLAS..:

Crisà, Elena ; Nosari, Annamaria ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e9792183 , 2023
Link: https://doi.org/10.1097/..
 
?
3

AVALON: The Italian cohort study on real‐life efficacy of h..:

Todisco, Elisabetta ; Papayannidis, Cristina ; Fracchiolla, Nicola...
Cancer.  129 (2023)  7 - p. 992-1004 , 2023
Link: https://doi.org/10.1002/..
 
?
4

PB2670: EQOL-MDS TRIAL: PATIENT-REPORTED OUTCOMES IN PATIEN..:

Oliva, Esther ; Iannì, Giuseppe ; Riva, Marta...
HemaSphere.  7 (2023)  S3 - p. e44846cb , 2023
Link: https://doi.org/10.1097/..
 
?
5

Danazol Treatment for Thrombocytopenia in Myelodysplastic S..:

Riva, Marta ; Bosi, Alessandro ; Rizzo, Lorenzo...
HemaSphere.  7 (2023)  4 - p. e867 , 2023
Link: https://doi.org/10.1097/..
 
?
6

A prognostic model to predict survival after 6 months of ru..:

Maffioli, Margherita ; Mora, Barbara ; Ball, Somedeb...
Blood Advances.  6 (2022)  6 - p. 1855-1864 , 2022
Link: https://doi.org/10.1182/..
 
?
7

Canakinumab as treatment for COVID-19-related pneumonia: A ..:

Generali, Daniele ; Bosio, Giancarlo ; Malberti, Fabio...
International Journal of Infectious Diseases.  104 (2021)  - p. 433-440 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Clinical, Radiometabolic and Immunologic Effects of Olapari..:

Schettini, Francesco ; Corona, Silvia Paola ; Giudici, Fabiola...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
9

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early cle..:

Pungolino, Ester ; D'adda, Mariella ; De Canal, Gabriella...
European Journal of Haematology.  107 (2021)  4 - p. 436-448 , 2021
Link: https://doi.org/10.1111/..
 
?
10

JAK Inhibition with Ruxolitinib in Patients with COVID-19 a..:

Vannucchi, Alessandro Maria ; Mortara, Andrea ; D'Alessio, Andrea...
Journal of Clinical Medicine.  10 (2021)  16 - p. 3752 , 2021
Link: https://doi.org/10.3390/..
 
?
11

Reply to "CLL and COVID-19 at the Hospital Clinic of Barcel..:

Reda, Gianluigi ; Noto, Alessandro ; Cassin, Ramona...
Leukemia.  34 (2020)  9 - p. 2531-2532 , 2020
Link: https://doi.org/10.1038/..
 
?
12

Immune system and angiogenesis-related potential surrogate ..:

Schettini, Francesco ; Sobhani, Navid ; Ianza, Anna...
Breast Cancer Research and Treatment.  184 (2020)  2 - p. 421-431 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Real‐world experience with decitabine as a first‐line treat..:

Bocchia, Monica ; Candoni, Anna ; Borlenghi, Erika...
Hematological Oncology.  37 (2019)  4 - p. 447-455 , 2019
Link: https://doi.org/10.1002/..
 
?
14

Infection control in patients with myelodysplastic syndrome..:

Girmenia, Corrado ; Candoni, Anna ; Delia, Mario...
Blood Reviews.  34 (2019)  - p. 16-25 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Second primary malignancies in ruxolitinib-treated myelofib..:

Maffioli, Margherita ; Giorgino, Toni ; Mora, Barbara...
Blood Advances.  3 (2019)  21 - p. 3196-3200 , 2019
Link: https://doi.org/10.1182/..
 
1-15